Related Experiment Video
Updated: Jul 17, 2026

Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020
Ischemic heart disease
1Department of Anesthesiology, Yale University School of Medicine, 333 Cedar Street, TMP-3, New Haven, CT 06520-8051, USA. shamsuddin.akhtar@yale.edu
Insights
Patients with ischemic heart disease (IHD) undergoing noncardiac surgery face significant risks. Comprehensive perioperative management, including hemodynamic control and aggressive postoperative care, is crucial for improving outcomes.
Area of Science:
- Cardiology
- Anesthesiology
- Perioperative Medicine
Background:
- Increasing numbers of patients with ischemic heart disease (IHD) are undergoing noncardiac surgery.
- Significant risks of perioperative morbidity and mortality are associated with IHD in this population.
Purpose of the Study:
- To review current strategies for managing patients with IHD undergoing noncardiac surgery.
- To identify key factors influencing perioperative outcomes in patients with IHD.
Main Methods:
- Review of existing risk stratification tools (e.g., Lee Cardiac Risk Index, ACC/AHA guidelines).
- Discussion of the role of biomarkers, hemodynamic management (beta-blockers, alpha-2 agonists), anti-inflammatory agents (statins), and revascularization.
- Emphasis on structured management protocols and anesthetic techniques.
- Highlighting the importance of postoperative care and management of secondary stresses.
Main Results:
- Current risk indices have limitations, and the role of biomarkers requires further definition.
- Hemodynamic control and anti-inflammatory modulation show promise in improving outcomes.
- Preoperative revascularization may have limited value.
- Postoperative management, including aggressive identification and treatment of myocardial injury and secondary stresses, is critical.
Conclusions:
- Optimal care for patients with IHD requires coordinated assessment and management across all perioperative phases.
- Structured protocols, hemodynamic augmentation, and vigilant postoperative care are essential for improving patient outcomes.
- Minimizing hemodynamic perturbations and addressing secondary stresses are key to reducing perioperative morbidity and mortality.
Abstract:
Because of changing demographics, increasing numbers of patients with IHD are presenting for noncardiac surgery, and the risks of perioperative morbidity and mortality are significant. The Lee Cardiac Risk Index is applicable in defining perioperative cardiac risk: however, ACC/AHA guidelines may not be applicable comprehensively. The role of biomarkers in risk stratification still needs to be defined. Structured management protocols that help assess, diagnose, and treat patients with IHD preoperatively are likely to help decrease postoperative morbidity and mortality, but clearly are not applicable to all patients. Augmented hemodynamic control with beta-blockers or alpha-2 agonists and modulating inflammation by statins can play an important role in improving outcomes in many patients with IHD; preoperative coronary revascularization may be of limited value. Intraoperative anesthetic management that minimizes hemodynamic perturbations is important; however, the choice of a particular technique typically is not critical. Of critical importance is the postoperative management of the patient. Postoperative myocardial injury should be identified, evaluated, and managed aggressively. Secondary stresses such as sepsis, extubation, and anemia, which can increase demand on the heart, should be treated or minimized. Clearly, optimal care of the patient with IHD entails closely coordinated assessment and management throughout the preoperative, intraoperative, and postoperative phases, if one is to optimize short- and long-term outcomes.
More Related Videos
10:21Evaluation of Hydration Status by Bioelectrical Impedance Vector Analysis in Patients with Ischemic Heart Disease Undergoing Exercise Stress Test
Published on: September 22, 2023
09:12Surgical Swine Model of Chronic Cardiac Ischemia Treated by Off-Pump Coronary Artery Bypass Graft Surgery
Published on: March 27, 2018
Related Concept Videos
Ischemic Heart Disease: Overview
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and narrowing...
Ischemic Stroke l: Introduction
Ischemic Stroke ll: Pathophysiology
Transient Ischemic Attack l: Introduction
Heart Failure I: Introduction
Rheumatic Heart Disease I: Introduction